Campo L, Mylotte J M
Department of Medicine, Mercy Hospital, Buffalo, New York.
Am J Med Sci. 1988 Dec;296(6):392-8. doi: 10.1097/00000441-198812000-00005.
The purpose of this study was to examine the use of microbiologic reports by physicians in prescribing antimicrobial agents in a community hospital setting. Patients were identified by daily review of all blood, urine, and sputum cultures that grew pathogen(s) during a 7-week period. Appropriateness of antibiotic therapy was based on results of antibiotic susceptibility testing of isolated pathogen(s). The physician response to culture results was evaluated on changes made in antimicrobial therapy. Seventy-one patients with 73 cultures (infections) were identified; 70% of the infections were community acquired. The frequency of each infection during the study period was: bacteremia (N = 12), pneumonia (N = 18), definite urinary tract infection (N = 26) and probable urinary tract infection (N = 17). Initial treatment was appropriate in 49 of 73 (67%) episodes; the organism(s) isolated were resistant to initial therapy in 24 of 85 (33%) episodes. After culture results were available, 34 of 73 (47%) regimens were changed, but only 50% of the changes were considered appropriate. Overall, there was no significant difference in the proportion of all treatment regimens considered appropriate before (67%) and after (56%) culture results were known. We conclude that results of cultures and antibiotic susceptibility data had little influence on appropriateness of antibiotic prescribing in the hospital setting.
本研究的目的是考察在社区医院环境中,医生在开具抗菌药物处方时对微生物学报告的使用情况。通过每日查阅在7周期间培养出病原体的所有血液、尿液和痰液培养物来确定患者。抗生素治疗的适宜性基于分离出的病原体的药敏试验结果。根据抗菌治疗的变化评估医生对培养结果的反应。共确定了71例患者的73次培养(感染);70%的感染为社区获得性感染。研究期间每种感染的发生频率为:菌血症(N = 12)、肺炎(N = 18)、确诊尿路感染(N = 26)和可能的尿路感染(N = 17)。73次发作中有49次(67%)初始治疗是适宜的;85次发作中有24次(33%)分离出的病原体对初始治疗耐药。培养结果出来后,73种治疗方案中有34种(47%)发生了改变,但只有50%的改变被认为是适宜的。总体而言,在知晓培养结果之前(67%)和之后(56%),所有被认为适宜的治疗方案比例没有显著差异。我们得出结论,培养结果和抗生素药敏数据对医院环境中抗生素处方的适宜性影响不大。